Moderna (MRNA) Gears Up for Q4 Earnings: Will It Top Estimates?

We expect Moderna (MRNA) to beat expectations when it reports fourth-quarter and full-year 2023 results on Feb 22, before the opening bell. In the last reported quarter, the company delivered an earnings surprise of 30.85%.Factors to NoteDuring the fourth quarter, sales of COVID-19 vaccines are likely to have declined significantly due to lower demand. The Zacks Consensus Estimate for fourth-quarter product sales is pegged at $2.45 billion.Due to the substantial fall in COVID-19 vaccine sales compared with ...